Bio-Techne Acquires Exosome Diagnostics In $250 Million Deal.

The Minneapolis Star Tribune (6/26, Carlson) reports that Bio-Techne Corp. has agreed to pay $250 million to acquire Exosome Diagnostics, a Boston-area firm that makes precision-medicine technology used to detect cancer without a tissue biopsy. According...